0000914190-21-000321.txt : 20210902 0000914190-21-000321.hdr.sgml : 20210902 20210902164836 ACCESSION NUMBER: 0000914190-21-000321 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210831 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlow Brenda S. CENTRAL INDEX KEY: 0001443851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 211233879 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-08-31 0000842023 BIO-TECHNE Corp TECH 0001443851 Furlow Brenda S. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 SVP - General Counsel Common Stock 2021-08-31 4 M 0 5000 125.05 A 12620 D Common Stock 2021-08-31 4 S 0 323 503.2383 D 12297 D Common Stock 2021-08-31 4 S 0 1569 505.2612 D 10728 D Common Stock 2021-08-31 4 S 0 3108 506.1167 D 7620 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 921 921 D Stock Options (Right to Buy) 125.05 2021-08-31 4 M 0 5000 0 D 2024-08-09 Common Stock 5000 16374 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 7339 7339 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 9786 9786 D Restricted Stock Units Common Stock 1969 1969 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 9968 9968 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 13290 13290 D Restricted Stock Units Common Stock 1679 1679 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 7492 7492 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 9990 9990 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 8325 8325 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 8325.0 8325.0 D Stock Options (Right to Buy) 372.44 2022-08-31 2028-03-01 Common Stock 10997 10997 D Restricted Stock Units Common Stock 1167 1167 D Stock Options (Right to Buy) 481.82 2028-08-06 Common Stock 4560 4560 D Stock Options (Right to Buy) 481.82 2028-08-06 Common Stock 6080 6080 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $503.06 to $503.43, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $504.63 to $505.57, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.92 to $506.40, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Fully exercisable. Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. /s/ Sarah Tucher as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed. 2021-09-02